The Vanguard Group just provided an update on share ownership of PDL BioPharma

The Vanguard Group just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though The Vanguard Group claims to own 13,352,288 shares. This represents 8.06% of PDL BioPharma.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever PDL BioPharma makes a similar move, sign up!

Other recent filings from the company include the following:

PDL BioPharma's President just picked up 240,200 shares - Sept. 13, 2017
PDL BioPharma's President just declared 0 ownership of the company. - Sept. 13, 2017
Securities to be offered to employees in employee benefit plans - Sept. 12, 2017
PDL: Cook Williams Communications, Inc - Sept. 11, 2017
Current report, items 7.01 and 9.01 - Sept. 11, 2017

Auto Refresh

Feedback